Extensive Gray Matter Volume Reduction in Treatment-Resistant Schizophrenia

BACKGROUND: Approximately one-third of people with schizophrenia are treatment-resistant and some do not achieve remission with clozapine, the gold-standard antipsychotic medication for treatment-resistant schizophrenia. This study compared global and regional brain volumes between treatment-respond...

Descripción completa

Detalles Bibliográficos
Autores principales: Anderson, Valerie M, Goldstein, Meghan E, Kydd, Robert R., Russell, Bruce R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540109/
https://www.ncbi.nlm.nih.gov/pubmed/25716781
http://dx.doi.org/10.1093/ijnp/pyv016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540109/
https://www.ncbi.nlm.nih.gov/pubmed/25716781
http://dx.doi.org/10.1093/ijnp/pyv016

Ejemplares similares